Outsourcing-Pharma presents its weekly round-up of the latest new appointments in the pharmaceutical industry, including news from Aptiv, Truveris and CMI.
Amrutanjan Health Care plans to add contract manufacturing and custom synthesis to services offered by loss making fine chemicals business, according to various reports.
UK drug major GSK has entered into a ‘strategic partnership’ with MaRS Innovation, a Canadian group focused on harnessing the commercial potential of the discovery pipelines of 16 top Toronto academic institutions in its network.
Double-digit growth in the Chinese pharmaceutical sector will increasingly make the nation a lucrative place for Western companies to do business, delegates heard at the InterPhex trade event in New York.
A US group representing hospitals in New York wants to accelerate clinical research process by improving trial access to electronic patient records, while maintaining patient privacy.
Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.
Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.
Clinical laboratory services company LabCorp saw its shares slide yesterday after cutting back its sales and earnings targets for 2009 in light of the economic downturn.
The UK launch of Eli Lilly’s pre-filled insulin device Humalog KwikPen offers the country’s 800,000 insulin-dependant diabetics a simplified treatment option, according to company development director Stuart Breslin.
Researchers from India and Japan claim to have developed a compact medical device capable of painlessly monitoring a patients insulin levels and administering the required dose.
GE Healthcare has announced its intention to invest $20m in radical
new technology, which will allow laboratory research results to be
transmitted and shared amongst doctors worldwide setting to define
a new age in patient care.
A new type of latex glove developed by Yulex Corp that is less
allergenic for medical and research staff has been given a green
light by the US Food and Drug Administration (FDA).
In-PharmaTechnologist.com and Outsourcing-Pharma.com journalist
Kirsty Barnes has received the honour of being announced among the
place winners of the 2006 Awards for Excellence in Health Care
Journalism (AHCJ).
The move towards electronic files is set to bring major benefits in
the clinical trials area especially in terms of patient
recruitment, new research suggests.
European healthcare organisations are being driven to outsource
more and more IT operations due to escalating financial burdens,
increasing complexity of IT systems, and new government
initiatives.
The move to make pharmaceutical companies more open to scrutiny has
taken a new direction as the US Food and Drug Administration (FDA)
moves to adopt a system that will allow the electronic coding of
crucial terms used in prescription...
Maxxon are to receive delivery of the first 5,000 batch of its
functional 3 cc Vacuum Operated Retractable Safety Syringe
("ReVac"), which is set to spark a price war amongst fellow
manufacturers in the Safety-engineered...
Companies filing for approval of their drugs in the US market must
now supply all information on the product's labelling and package
insert in an electronic format, according to the Food and Drug
Administration (FDA).
The future of Medisys' Futura safety syringe looked to be in doubt
again yesterday after the company conceded that its timetable for
launch of the safety syringe, originally due for launch in 2001,
had been put back yet again.
Needle-free injection systems are finally emerging as a serious
alternative to traditional syringes, despite first being introduced
in the middle of the last century.
